A prospective longitudinal observational study of health status in patients with lung cancer (TOSEI-LC)

A prospective longitudinal observational study of health status in patients with lung cancer (TOSEI-LC) - TOSEI-LC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030481

Enrollment

Registered

2017-12-21

Start date

2018-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Histologically or cytologically confirmed lung cancer 2. Clinical stage IIIB, IV or postoperative recurrence 3. No prior chemotherapy (Adjuvant chemotherapy is permitted) 4. Estimated life expectancy of at least 3 months 5. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who are difficult to answer in the questionnaire form 2. Patients who are difficult to perform exercise test 3. Patients who have been judged by the investigator to be inappropriate in this clinical trial for other reasons

Design outcomes

Primary

Measure	Time frame
EORTC-QLQ-C30 (Summary score)	—

Secondary

Measure	Time frame
EORTC-QLQ-C30 (all items), SF-36, SGRQ, BFI, HADS, EQ-5D-5L, mMRC, Dyspnea-12, 6-minutes walk distance, pulmonary function test (FVC, DLco, FEV1), Grip strength test, Lower limb muscle strength test. Differences when interstitial pneumonia or chronic obstructive pulmonary disease is complicated	—

Countries

Japan

Contacts

Public ContactAtsushi Suzuki

Tosei General Hospital Department of Respiratory Medicine and Allergy

lung@tosei.or.jp+81561825101

Outcome results